Trials / Completed
CompletedNCT06597500
A Study to Evaluate the Effect of Itraconazole on the Concentration of GSK3923868 in the Blood in Healthy Participants
A Single-Centre, Open-Label, Single Sequence Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of Single Inhaled Doses of GSK3923868 in Healthy Participants
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate how itraconazole affects the blood concentration of GSK3923868 in healthy adults.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | GSK3923868 | GSK3923868 will be administered. |
| DRUG | Itraconazole | Itraconazole will be administered. |
Timeline
- Start date
- 2024-09-30
- Primary completion
- 2024-12-16
- Completion
- 2024-12-23
- First posted
- 2024-09-19
- Last updated
- 2025-03-07
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT06597500. Inclusion in this directory is not an endorsement.